Skip to main content
. 2023 Jun 30;16:17562864231181177. doi: 10.1177/17562864231181177

Figure 2.

Figure 2.

(a) Number of relapses and (b) relapse rates per patient-year before and after eculizumab (data for the effectiveness analysis set, n = 68).